Medical management of contact dermatitis

Giornale Italiano di Dermatologia e Venereologia

Volumn 144, Issue 5, 2009, Pages 537-540

  Alexandroff, A B ^a   Johnston, G A ^a  

^a LEICESTER ROYAL INFIRMARY   (United Kingdom)

Author keywords

Azathioprine; Ciclosporin; Dermatitis, allergic contact; Dermatitis, irritant; Emollients; Methotrexate; Tacrolimus

Indexed keywords

2 BROMO 2 BROMOMETHYLGLUTARONITRILE; ALITRETINOIN; ANTIBIOTIC AGENT; AZATHIOPRINE; BETAMETHASONE; BETAMETHASONE DIPROPIONATE; BETAMETHASONE VALERATE; BETNOVATE N; CALCINEURIN INHIBITOR; CORTICOSTEROID; CYCLOSPORIN A; EMOLLIENT AGENT; HAIR DYE; ISOEUGENOL; METHOTREXATE; PIMECROLIMUS; PLASTIC; POLYVINYLCHLORIDE; PREDNISOLONE; SOAP; TACROLIMUS; THIOPURINE METHYLTRANSFERASE; UNCLASSIFIED DRUG;

ADULT; ANAMNESIS; ATOPIC DERMATITIS; CHEILITIS; CLINICAL EXAMINATION; CLINICAL TRIAL; CONTACT DERMATITIS; DRUG DOSE REDUCTION; DRUG NOMENCLATURE; DRUG POTENCY; DRUG SAFETY; ECZEMA; ENZYME ACTIVITY; EXPOSURE; GLOVE; HUMAN; IRRITANT DERMATITIS; PATCH TEST; PRICK TEST; PROTECTIVE EQUIPMENT; RADIOALLERGOSORBENT TEST; RECOMMENDED DRUG DOSE; REVIEW; SKIN ALLERGY; SKIN ATROPHY; SKIN INFECTION; SYSTEMIC THERAPY; VESICULAR RASH;

EID: 73849138169     PISSN: 03920488     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (34)

1. Alexandroff AB, Burova E. Whither... the future for contact dermatitis? A report from the 2007 International Review of Current Problems in Contact Dermatitis. Br J Dermatol 2008; 159:1229-1231.
2. Meyer JD, Chen Y, Holt DL, Beck MH, Cherry NM. Occupational contact dermatitis in the UK: a surveillance report from EPIDERM and OPRA. Occup Med (Lond) 2000;50:265-73.
3. Alexandroff AB, Gawkrodger DJ. Update on contact dermatitis 2007: Medical pearls from the annual meeting of the British Contact Dermatitis Society at the annual meeting of the British Association of Dermatologists. J Dermatol Sci 2008;51:220-3.
4. Singh P, Singh M, Chowdhury MMU, Maibach HI. Irritant dermatitis due to occlusive gloves: clinical manifestations. In: Chowdhury MMU, Maibach HI, editors. Latex intolerance: basic science, epidemiology, and clinical management. CRC Press, London; 2009. p. 141-5.
5. Fowler JF, Jr. Late patch test reaction to acrylates in a dental worker. Am J Contact Dermat 1999;10:224-5.
6. Mirshahpanah P, Maibach HI. Relationship of patch test positivity in a general versus an eczema population. Contact Dermatitis 2007;56:125-30.
7. McFadden JP, White IR, Frosch PJ, Sosted H, Johansen JD, Menne T. Allergy to hair dye. BMJ 2007;334:220.
8. White JM, White IR, Glendinning A, Fleming J, Jefferies D, Basketter DA et al. Frequency of allergic contact dermatitis to isoeugenol is increasing: a review of 3636 patients tested from 2001 to 2005. Br J Dermatol 2007;157:580-2.
9. Thomas CL, Statham BN, Chowdhury MMU, English JSC, Gawkrodger DJ, Green CM et al. The frequency of nickel allergy in patch-tested female patients: age-stratified data from nine UK centres for 2004-2005. Br J Dermatol 2008;157:84.
10. Johnston GA, Nicolaou N, Chowdhury MMU. Management of hand dermatitis. I n: Chowdhury MMU, Maibach HI, editors. Latex intolerance: basic science, epidemiology, and clinical management. CRC Press, London; 2009. p. 151-62.
11. Zhai H, Anigbogu A, Maibach HI. Treatment of irritant and allergic contact dermatitis. In: Kanerva L, Eisner P, Wahlberg JE, Maibach HI, editors. Handbook of occupational dermatology. Berlin: Springer-Verlag; 2000.
12. Williams HC. Established corticosteroid creams should be applied only once daily in patients with atopic eczema. BMJ 2007;334:1272.
13. Thomas KS, Armstrong S, Avery A, Po AL, O'Neill C, Young S et al. Randomised controlled trial of short bursts of a potent topical corticosteroid versus prolonged use of a mild preparation for children with mild or moderate atopic eczema. BMJ 2002;324:768.
14. Katsarou A, Armenaka M, Vosynioti V, Lagogianni E, Kalogeromitros D, Katsambas A. Tacrolimus ointment 0.1% in the treatment of allergic contact eyelid dermatitis. J Eur Acad Dermatol Venereol 2009;23:382-7.
15. Mensing CO, Mensing CH, Mensing H. Treatment with pimecrolimus cream 1% clears irritant dermatitis of the periocular region, face and neck. Int J Dermatol 2008;47:960-4.
16. Remitz A, Reitamo S. Long-term safety of tacrolimus ointment in atopic dermatitis. Expert Opin Drug Saf 2009;8:501-6.
17. Birnie AJ, Bath-Hextall FJ, Ravenscroft JC, Williams HC. Interventions to reduce Staphylococcus aureus in the management of atopic eczema. Cochrane Database Syst Rev 2008;CD003871.
18. Gennari L, Bilezikian JP. Glucocorticoid-induced osteoporosis: hope on the HORIZON. Lancet 2009;373:1225-6.
19. Covar RA, Leung DY, McCormick D, Steelman J, Zeitler P, Spann JD. Risk factors associated with glucocorticoid-induced adverse effects in children with severe asthma. J Allergy Clin Immunol 2000;106:651-9.
20. Klein BE, Klein R, Lee KE, Danforth LG. Drug use and five-year incidence of age-related cataracts: The Beaver Dam Eye Study. Ophthalmology 2001;108:1670-4.
21. Chadha V, Cruickshank I, Swingler R, Sanders R. Advanced glaucomatous visual loss and oral steroids. BMJ 2008;337:a670.
22. Epstein E. Hand dermatitis: practical management and current concepts. J Am Acad Dermatol 1984;10:395-424.
23. Granlund H, Erkko P, Eriksson E, Reitamo S. Comparison of cyclosporine and topical betamethasone-17,21-dipropionate in the treatment of severe chronic hand eczema. Acta Derm Venereol 1996;76:371-6.
24. Lakshmi C, Srinivas CR, Jayaraman A. Ciclosporin in parthenium dermatitis-a report of 2 cases. Contact Dermatitis 2008;59:245-8.
25. Jacob SE. Ciclosporin ophthalmic emulsion - a novel therapy for benzyl alcohol-associated eyelid dermatitis. Contact Dermatitis 2008;58:169-70.
26. Berth-Jones J. The use of Ciclosporin in psoriasis. J Dermatolog Treat 2005;16:258-77.
27. Alexandroff AB, Pauriah M, Camp RD, Lang CC, Struthers AD, Armstrong DJ. More than skin deep - atherosclerosis as a systemic manifestation of psoriasis. Br J Dermatol 2009;161:1-7.
28. van den Borne BE, Landewe RB, Houkes I, Schild F, van der Heyden PC, Hazes JM et al. No increased risk of malignancies and mortality in cyclosporin A-treated patients with rheumatoid arthritis. Arthritis Rheum 1998;41:1930-7.
29. Meggitt SJ, Gray JC, Reynolds NJ. Azathioprine dosed by thiopurine methyltransferase activity for moderate-to-severe atopic eczema: a double-blind, randomised controlled trial. Lancet 2006;367:839-46.
30. Berth-Jones J, Takwale A, Tan E, Barclay G, Agarwal S, Ahmed I et al. Azathioprine in severe adult atopic dermatitis: a double-blind, placebo-controlled, crossover trial. Br J Dermatol 2002;147:324-30.
31. Wise M, Callen JP. Azathioprine: a guide for the management of dermatology patients. Dermatol Ther 2007;20:206-15.
32. Lauerma AI, Koivuluhta M, Alenius H. Recalcitrant allergic contact dermatitis from azathioprine tablets. Contact Dermatitis 2001;44:129.
33. Burden AD, Beck MH. Contact hypersensitivity to azathioprine. Contact Dermatitis 1992;27:329-30.
34. Sharma VK, Bhat R, Sethuraman G, Manchanda Y Treatment of parthenium dermatitis with methotrexate. Contact Dermatitis 2007;57:118-9.